| Year |
Citation |
Score |
| 2022 |
Lane GI, Dupati A, Qi J, Ferrante S, Dunn RL, Paudel R, Wittmann D, Wallner L, Berry DL, Ellimoottil C, Montie J, Clemens JQ. Factors Associated with Decision Aid Use in Localized Prostate Cancer. Urology Practice. 9: 108-115. PMID 35722246 DOI: 10.1097/upj.0000000000000283 |
0.366 |
|
| 2022 |
Radhakrishnan A, Wallner LP, Skolarus TA, George AK, Rosenberg BH, Abrahamse P, Hawley ST. Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer. The Journal of Urology. 101097JU000000000000. PMID 35522191 DOI: 10.1097/JU.0000000000002734 |
0.367 |
|
| 2022 |
Kobayashi LC, Westrick AC, Doshi A, Ellis KR, Jones CR, LaPensee E, Mondul AM, Mullins MA, Wallner LP. Reply to "Noncancer comparators in cancer survivorship studies". Cancer. PMID 35503812 DOI: 10.1002/cncr.34254 |
0.308 |
|
| 2021 |
Radhakrishnan A, Wallner LP, Skolarus TA, Shahinian VB, Abrahamse PH, Fetters MD, Hawley ST. Primary Care Physician Perspectives on Low Risk Prostate Cancer Management: Results of a National Survey. Urology Practice. 8: 515-522. PMID 35969833 DOI: 10.1097/UPJ.0000000000000231 |
0.356 |
|
| 2020 |
Radhakrishnan A, Wallner LP, Skolarus TA, Abrahamse PH, Kollipara AS, Katz SJ, Hawley ST. Primary Care Providers' Perceptions About Participating in Low-Risk Prostate Cancer Treatment Decisions. Journal of General Internal Medicine. PMID 33123958 DOI: 10.1007/s11606-020-06318-8 |
0.394 |
|
| 2020 |
Radhakrishnan A, Reyes-Gastelum D, Gay B, Hawley ST, Hamilton AS, Ward KC, Wallner LP, Haymart MR. Primary care provider involvement in thyroid cancer survivorship care. The Journal of Clinical Endocrinology and Metabolism. PMID 32639557 DOI: 10.1210/Clinem/Dgaa437 |
0.367 |
|
| 2020 |
Wallner LP, Abrahamse P, Radhakrishnan A, An LC, Griggs JJ, Schott AF, Ayanian J, Sales A, Katz SJ, Hawley ST. Improving the delivery of team-based survivorship care after primary breast cancer treatment through a multi-level intervention. Journal of Clinical Oncology. 38: 7056-7056. DOI: 10.1200/Jco.2020.38.15_Suppl.7056 |
0.376 |
|
| 2019 |
Chen DW, Reyes-Gastelum D, Wallner LP, Papaleontiou M, Hamilton AS, Ward KC, Hawley ST, Zikmund-Fisher BJ, Haymart MR. Disparities in risk perception of thyroid cancer recurrence and death. Cancer. PMID 31869452 DOI: 10.1002/Cncr.32670 |
0.359 |
|
| 2019 |
Baydoun M, Barton DL, Peterson M, Wallner LP, Visovatti MA, Arslanian-Engoren C, Choi SW. Yoga for Cancer-related Fatigue in Survivors of Hematopoietic Cell Transplantation: A Feasibility Study. Journal of Pain and Symptom Management. PMID 31765760 DOI: 10.1016/J.Jpainsymman.2019.11.012 |
0.361 |
|
| 2019 |
Fauer AJ, Davis MA, Choi SW, Wallner LP, Friese CR. Use of gabapentinoid medications among US adults with cancer, 2005-2015. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 31650294 DOI: 10.1007/S00520-019-05100-9 |
0.355 |
|
| 2019 |
Evron JM, Reyes-Gastelum D, Banerjee M, Scherer LD, Wallner LP, Hamilton AS, Ward KC, Hawley ST, Zikmund-Fisher BJ, Haymart MR. Role of Patient Maximizing-Minimizing Preferences in Thyroid Cancer Surveillance. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901411. PMID 31573822 DOI: 10.1200/Jco.19.01411 |
0.377 |
|
| 2019 |
Wallner LP, Reyes-Gastelum D, Hamilton AS, Ward KC, Hawley ST, Haymart MR. Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1802228. PMID 31283406 DOI: 10.1200/Jco.18.02228 |
0.367 |
|
| 2019 |
Radhakrishnan A, Li Y, Furgal AKC, Hamilton AS, Ward KC, Jagsi R, Katz SJ, Hawley ST, Wallner LP. Provider Involvement in Care During Initial Cancer Treatment and Patient Preferences for Provider Roles After Initial Treatment. Journal of Oncology Practice. JOP1800497. PMID 30856036 DOI: 10.1200/Jop.18.00497 |
0.415 |
|
| 2019 |
Wallner LP, Li Y, McLeod MC, Gargaro J, Kurian AW, Jagsi R, Radhakrishnan A, Hamilton AS, Ward KC, Hawley ST, Katz SJ. Primary care provider-reported involvement in breast cancer treatment decisions. Cancer. PMID 30707773 DOI: 10.1002/Cncr.31998 |
0.408 |
|
| 2019 |
Veenstra CM, Wallner LP, Abrahamse PH, Janz NK, Katz SJ, Hawley ST. Understanding the engagement of key decision support persons in patient decision making around breast cancer treatment. Cancer. PMID 30633326 DOI: 10.1002/Cncr.31956 |
0.338 |
|
| 2019 |
Evron J, Reyes-Gastelum D, Zikmund-Fisher B, Banerjee M, Hawley S, Scherer L, Wallner L, Hamilton A, Ward K, Haymart M. MON-557 Resource Utilization in the Surveillance of Differentiated Thyroid Cancer: The Impact of Patient Preferences Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Mon-557 |
0.359 |
|
| 2019 |
Wallner LP, Abrahamse P, Radhakrishnan A, Hamilton AS, Ward KC, Hawley ST, Katz SJ. Primary care providers propensity to order non-recommended surveillance testing after curative breast cancer treatment. Journal of Clinical Oncology. 37: 52-52. DOI: 10.1200/Jco.2019.37.27_Suppl.52 |
0.38 |
|
| 2018 |
Radhakrishnan A, Chandler McLeod M, Hamilton AS, Ward KC, Katz SJ, Hawley ST, Wallner LP. Preferences for Physician Roles in Follow-up Care During Survivorship: Do Patients, Primary Care Providers, and Oncologists Agree? Journal of General Internal Medicine. PMID 30284174 DOI: 10.1007/S11606-018-4690-5 |
0.3 |
|
| 2018 |
Jagsi R, Ward KC, Abrahamse PH, Wallner LP, Kurian AW, Hamilton AS, Katz SJ, Hawley ST. Unmet Need for Clinician Engagement Regarding Financial Toxicity After Diagnosis of Breast Cancer. Cancer. PMID 30033631 DOI: 10.1002/Cncr.31532 |
0.422 |
|
| 2018 |
Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D'Agostino R, Loo RK, Aaronson DS, Horwitz RI, Jacobsen SJ. The use of 5-alpha reductase inhibitors to manage benign prostatic hyperplasia and the risk of all-cause mortality. Urology. PMID 29906480 DOI: 10.1016/J.Urology.2018.05.033 |
0.357 |
|
| 2018 |
Shumway DA, Griffith KA, Hawley ST, Wallner LP, Ward KC, Hamilton AS, Morrow M, Katz SJ, Jagsi R. Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer. Cancer. PMID 29669187 DOI: 10.1002/Cncr.31378 |
0.402 |
|
| 2018 |
Katz SJ, Ward KC, Hamilton AS, Mcleod MC, Wallner LP, Morrow M, Jagsi R, Hawley ST, Kurian AW. Gaps in Receipt of Clinically Indicated Genetic Counseling After Diagnosis of Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017762369. PMID 29528794 DOI: 10.1200/Jco.2017.76.2369 |
0.33 |
|
| 2018 |
Wallner LP, Li Y, McLeod C, Radhakrishnan A, Hawley ST, Katz SJ. Primary care provider-reported participation in breast cancer treatment decision making. Journal of Clinical Oncology. 36: 78-78. DOI: 10.1200/Jco.2018.36.7_Suppl.78 |
0.436 |
|
| 2018 |
Wallner LP, Reyes-Gastelum D, Hamilton AS, Ward KC, Hawley ST, Haymart MR. Choice of radioactive iodine treatment for thyroid cancer: Results from a population-based survey. Journal of Clinical Oncology. 36: 159-159. DOI: 10.1200/Jco.2018.36.30_Suppl.159 |
0.358 |
|
| 2018 |
Jagsi R, Ward KC, Abrahamse P, Wallner LP, Kurian AW, Hamilton AS, Katz SJ, Hawley ST. Unmet need for clinician engagement about financial toxicity after diagnosis of breast cancer. Journal of Clinical Oncology. 36: 10080-10080. DOI: 10.1200/Jco.2018.36.15_Suppl.10080 |
0.417 |
|
| 2018 |
Radhakrishnan A, Katz SJ, Hawley ST, Wallner LP. Patient and provider preferences for physician roles in breast cancer survivorship care. Journal of Clinical Oncology. 36: 10051-10051. DOI: 10.1200/Jco.2018.36.15_Suppl.10051 |
0.413 |
|
| 2017 |
Wallner LP, Griggs JJ. Advancing the Science of Cancer Health Disparities Research. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017760496. PMID 29087770 DOI: 10.1200/Jco.2017.76.0496 |
0.327 |
|
| 2017 |
Wallner LP, Slezak JM, Loo RK, Bastani R, Jacobsen SJ. Ten-Year Trends in Preventive Service Use Before and After Prostate Cancer Diagnosis: A Comparison with Noncancer Controls. The Permanente Journal. 21. PMID 29035180 DOI: 10.7812/Tpp/16-184 |
0.477 |
|
| 2017 |
Jagsi R, Abrahamse PH, Lee KL, Wallner LP, Janz NK, Hamilton AS, Ward KC, Morrow M, Kurian AW, Friese CR, Hawley ST, Katz SJ. Treatment decisions and employment of breast cancer patients: Results of a population-based survey. Cancer. PMID 28990155 DOI: 10.1002/cncr.30959 |
0.425 |
|
| 2017 |
Veenstra CM, Wallner LP, Jagsi R, Abrahamse P, Griggs JJ, Bradley CJ, Hawley ST. Long-Term Economic and Employment Outcomes Among Partners of Women With Early-Stage Breast Cancer. Journal of Oncology Practice. JOP2017023606. PMID 28880714 DOI: 10.1200/Jop.2017.023606 |
0.383 |
|
| 2017 |
Lee KL, Janz NK, Zikmund-Fisher BJ, Jagsi R, Wallner LP, Kurian AW, Katz SJ, Abrahamse P, Hawley ST. What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment? Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X17724441. PMID 28814131 DOI: 10.1177/0272989X17724441 |
0.414 |
|
| 2017 |
Wallner LP, Li Y, Furgal AKC, Friese CR, Hamilton AS, Ward KC, Jagsi R, Katz SJ, Hawley ST. Patient Preferences for Primary Care Provider Roles in Breast Cancer Survivorship Care. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017731307. PMID 28700276 DOI: 10.1200/Jco.2017.73.1307 |
0.395 |
|
| 2017 |
Wallner LP, Li Y, McLeod MC, Hamilton AS, Ward KC, Veenstra CM, An LC, Janz NK, Katz SJ, Hawley ST. Decision-support networks of women newly diagnosed with breast cancer. Cancer. PMID 28640360 DOI: 10.1002/Cncr.30848 |
0.394 |
|
| 2017 |
Wallner LP, Jacobsen SJ. Prostate cancer in black men: Is it time for personalized screening approaches? Cancer. PMID 28436012 DOI: 10.1002/Cncr.30685 |
0.438 |
|
| 2017 |
Katz SJ, Wallner LP, Abrahamse PH, Janz NK, Martinez KA, Shumway DA, Hamilton AS, Ward KC, Resnicow KA, Hawley ST. Treatment experiences of Latinas after diagnosis of breast cancer. Cancer. PMID 28398629 DOI: 10.1002/Cncr.30702 |
0.396 |
|
| 2017 |
Katz SJ, Janz NK, Abrahamse P, Wallner LP, Hawley ST, An LC, Ward KC, Hamilton AS, Morrow M, Jagsi R. Patient Reactions to Surgeon Recommendations About Contralateral Prophylactic Mastectomy for Treatment of Breast Cancer. Jama Surgery. PMID 28384687 DOI: 10.1001/Jamasurg.2017.0458 |
0.427 |
|
| 2017 |
Wallner LP, Janz NK, Li Y, Friese CR, Ward KC, Hamilton AS, Katz SJ, Hawley ST. Worry about recurrence and patient preferences for provider roles in collaborative breast cancer care. Journal of Clinical Oncology. 35: 158-158. DOI: 10.1200/Jco.2017.35.8_Suppl.158 |
0.465 |
|
| 2017 |
Wallner LP, Li Y, McLeod C, Hamilton AS, Ward KC, Veenstra CM, An LC, Janz NK, Katz SJ, Hawley ST. Size and influence of the decision support networks of women newly diagnosed with breast cancer. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.15_Suppl.E18012 |
0.359 |
|
| 2016 |
Wallner LP, Abrahamse P, Uppal JK, Friese CR, Hamilton AS, Ward KC, Katz SJ, Hawley ST. Involvement of Primary Care Physicians in the Decision Making and Care of Patients With Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 3969-3975. PMID 28440678 DOI: 10.1200/Jco.2016.67.8896 |
0.451 |
|
| 2016 |
Wallner LP, Bradley C, Hawley ST. Long-term employment outcomes among partners of patients with early-stage breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 12. PMID 28152946 DOI: 10.1200/Jco.2016.34.7_Suppl.12 |
0.393 |
|
| 2016 |
Janz NK, Jagsi R, Griffith KA, Friese CR, Kurian AW, Morrow M, Wallner LP, Katz SJ. Recurrence risk perception and quality of life after treatment of breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 175. PMID 28152870 DOI: 10.1200/Jco.2016.34.7_Suppl.175 |
0.399 |
|
| 2016 |
Wallner LP, DiBello JR, Li BH, Van Den Eeden SK, Weinmann S, Ritzwoller DP, Abell JE, D'Agostino R, Loo RK, Aaronson DS, Richert-Boe K, Horwitz RI, Jacobsen SJ. 5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clinic Proceedings. 91: 1717-1726. PMID 28126151 DOI: 10.1016/j.mayocp.2016.07.023 |
0.304 |
|
| 2016 |
Hawley ST, Janz NK, Griffith KA, Jagsi R, Friese CR, Kurian AW, Hamilton AS, Ward KC, Morrow M, Wallner LP, Katz SJ. Recurrence risk perception and quality of life following treatment of breast cancer. Breast Cancer Research and Treatment. PMID 28004220 DOI: 10.1007/S10549-016-4082-7 |
0.402 |
|
| 2016 |
Wallner LP, Martinez KA, Li Y, Jagsi R, Janz NK, Katz SJ, Hawley ST. Use of Online Communication by Patients With Newly Diagnosed Breast Cancer During the Treatment Decision Process. Jama Oncology. PMID 27468161 DOI: 10.1001/Jamaoncol.2016.2070 |
0.391 |
|
| 2016 |
Martinez KA, Resnicow K, Williams GC, Silva M, Abrahamse P, Shumway DA, Wallner LP, Katz SJ, Hawley ST. Does physician communication style impact patient report of decision quality for breast cancer treatment? Patient Education and Counseling. PMID 27395750 DOI: 10.1016/J.Pec.2016.06.025 |
0.384 |
|
| 2016 |
Janz NK, Li Y, Beesley LJ, Wallner LP, Hamilton AS, Morrison RA, Hawley ST. Worry about recurrence in a multi-ethnic population of breast cancer survivors and their partners. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 27378380 DOI: 10.1007/S00520-016-3314-Z |
0.407 |
|
| 2016 |
Reading SR, Porter KR, Hsu JY, Wallner LP, Loo RK, Jacobsen SJ. Racial and Ethnic Variation in Time to Prostate Biopsy after an Elevated Screening Level of Serum PSA. Urology. PMID 27316374 DOI: 10.1016/J.Urology.2016.06.008 |
0.38 |
|
| 2016 |
Wallner LP, Abrahamse P, Friese CR, Katz SJ, Hawley ST. Patient preferences for provider roles in collaborative breast cancer survivorship care. Journal of Clinical Oncology. 34: 184-184. DOI: 10.1200/Jco.2017.35.5_Suppl.99 |
0.448 |
|
| 2016 |
Wallner LP, Abrahamse P, Friese CR, Katz SJ, Hawley ST. Primary care provider engagement about breast cancer care during treatment: Results from the iCanCare Study. Journal of Clinical Oncology. 34: 101-101. DOI: 10.1200/Jco.2016.34.3_Suppl.101 |
0.42 |
|
| 2016 |
Reading S, Porter K, Hsu J, Wallner L, Loo R, Jacobsen S. Pd26-04 Racial And Ethnic Variation In Time To Prostate Biopsy After An Elevated Psa Blood Level Screening Result The Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.365 |
0.331 |
|
| 2016 |
Wallner L, DiBello J, Li B, Van Den Eeden S, Weinmann S, Ritzwoller D, Abell J, D'Agostino R, Loo R, Aaronson D, Richert-Boe K, Horwitz R, Jacobsen S. MP04-02 5-ALPHA REDUCTASE INHIBITORS AND THE RISK OF PROSTATE CANCER MORTALITY IN MEN TREATED FOR BENIGN PROSTATIC HYPERPLASIA Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1937 |
0.429 |
|
| 2015 |
Wallner LP, Slezak JM, Quinn VP, Loo RK, Schottinger JE, Bastani R, Jacobsen SJ. Quality of preventive care before and after prostate cancer diagnosis. Journal of Men's Health. 11: 14-21. PMID 26430473 |
0.397 |
|
| 2015 |
Wallner LP, Hsu JW, Loo RK, Palmer-Toy DE, Schottinger JE, Jacobsen SJ. Trends in Prostate-specific Antigen Screening, Prostate Biopsies, Urology Visits, and Prostate Cancer Treatments From 2000 to 2012. Urology. 86: 498-505. PMID 26123517 DOI: 10.1016/J.Urology.2015.04.063 |
0.444 |
|
| 2015 |
Soffer D, Shi J, Chung J, Schottinger JE, Wallner LP, Chlebowski RT, Lentz SE, Haque R. Metformin and breast and gynecological cancer risk among women with diabetes. Bmj Open Diabetes Research & Care. 3: e000049. PMID 25664181 DOI: 10.1136/Bmjdrc-2014-000049 |
0.408 |
|
| 2015 |
Wallner LP, Slezak JM, Loo RK, Quinn VP, Van Den Eeden SK, Jacobsen SJ. Progression and treatment of incident lower urinary tract symptoms (LUTS) among men in the California Men's Health Study. Bju International. 115: 127-33. PMID 24840926 DOI: 10.1111/Bju.12810 |
0.318 |
|
| 2015 |
Wallner LP, Abrahamse P, Friese CR, Katz SJ, Hawley ST. Primary care quality and breast cancer care engagement during treatment: Results from the iCanCare Study. Journal of Clinical Oncology. 33: e20637-e20637. DOI: 10.1200/Jco.2015.33.15_Suppl.E20637 |
0.437 |
|
| 2015 |
Hawley ST, Janz NK, Wallner LP, Katz SJ. Use of online communication and social media by newly diagnosed breast cancer patients: Results from the iCanCare Study. Journal of Clinical Oncology. 33: 6518-6518. DOI: 10.1200/Jco.2015.33.15_Suppl.6518 |
0.424 |
|
| 2014 |
Haque R, Van Den Eeden SK, Wallner LP, Richert-Boe K, Kallakury B, Wang R, Weinmann S. Association of body mass index and prostate cancer mortality. Obesity Research & Clinical Practice. 8: e374-81. PMID 25091359 DOI: 10.1016/J.Orcp.2013.06.002 |
0.443 |
|
| 2014 |
Wallner LP, Slezak JM, Loo RK, Bastani R, Jacobsen SJ. Trends in the quality of preventive care before and after prostate cancer diagnosis. Journal of Clinical Oncology. 32: 6605-6605. DOI: 10.1200/Jco.2014.32.15_Suppl.6605 |
0.491 |
|
| 2013 |
Wallner LP, Jacobsen SJ. Prostate-specific antigen and prostate cancer mortality: a systematic review. American Journal of Preventive Medicine. 45: 318-26. PMID 23953359 DOI: 10.1016/J.Amepre.2013.04.015 |
0.434 |
|
| 2013 |
Jackson RE, Casanova NF, Wallner LP, Dunn RL, Hedgepeth RC, Faerber GJ, Wei JT. Risk factors for delayed hematuria following photoselective vaporization of the prostate. The Journal of Urology. 190: 903-8. PMID 23538242 DOI: 10.1016/J.Juro.2013.03.070 |
0.392 |
|
| 2013 |
Chao C, Jacobsen SJ, Xu L, Wallner LP, Porter KR, Williams SG. Use of statins and prostate cancer recurrence among patients treated with radical prostatectomy. Bju International. 111: 954-62. PMID 23464862 DOI: 10.1111/J.1464-410X.2012.11639.X |
0.483 |
|
| 2013 |
Chao C, Williams SG, Xu L, Chen J, Wallner LP, Porter KR, Jacobsen SJ. Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy. Cancer Letters. 335: 214-8. PMID 23419526 DOI: 10.1016/J.Canlet.2013.02.017 |
0.46 |
|
| 2013 |
Wallner LP, Frencher SK, Hsu JW, Chao CR, Nichol MB, Loo RK, Jacobsen SJ. Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population. Bju International. 111: 1245-52. PMID 23320750 DOI: 10.1111/J.1464-410X.2012.11651.X |
0.434 |
|
| 2013 |
Wallner LP, Wang R, Jacobsen SJ, Haque R. Androgen deprivation therapy for treatment of localized prostate cancer and risk of second primary malignancies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 313-6. PMID 23292083 DOI: 10.1158/1055-9965.Epi-12-1137 |
0.472 |
|
| 2012 |
Wallner L, Frencher S, Hsu JW, Loo R, Huang J, Nichol M, Jacobsen S. Prostate cancer screening trends in a large, integrated health care system. The Permanente Journal. 16: 4-9. PMID 23012592 |
0.343 |
|
| 2012 |
Ritchey J, Gay EG, Spencer BA, Miller DC, Wallner LP, Stewart AK, Dunn RL, Litwin MS, Wei JT. Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States. The Journal of Urology. 188: 769-74. PMID 22818140 DOI: 10.1016/J.Juro.2012.04.106 |
0.474 |
|
| 2012 |
Chao CR, Xu L, Wallner LP, Porter KP, Jacobsen S, Williams SG. Abstract 647: Use of statin and risk of prostate cancer recurrence among patients who received radical prostatectomy Cancer Research. 72: 647-647. DOI: 10.1158/1538-7445.Am2012-647 |
0.459 |
|
| 2012 |
Wallner LP, Slezak JM, Chao CR, Haque R, Quinn VP, Jacobsen SJ. Abstract 3578: The use of preventive services among prostate cancer survivors Cancer Research. 72: 3578-3578. DOI: 10.1158/1538-7445.Am2012-3578 |
0.497 |
|
| 2011 |
Wallner LP, Morgenstern H, McGree ME, Jacobson DJ, St Sauver JL, Jacobsen SJ, Sarma AV. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 501-8. PMID 21242331 DOI: 10.1158/1055-9965.Epi-10-1006 |
0.548 |
|
| 2011 |
Wallner LP, Morgenstern H, McGree ME, Jacobson DJ, St Sauver JL, Jacobsen SJ, Sarma AV. The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study. Urology. 77: 137-41. PMID 21094992 DOI: 10.1016/J.Urology.2010.07.516 |
0.528 |
|
| 2011 |
Wallner LP, Morgenstern H, McGree ME, Jacobson DJ, St Sauver JL, Jacobsen SJ, Sarma AV. The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study. Bju International. 107: 929-35. PMID 20880183 DOI: 10.1111/J.1464-410X.2010.09703.X |
0.594 |
|
| 2011 |
Jacobsen SJ, Slezak JM, Wallner LP, Haque R, Tseng HF, Loo RK, Quinn VP. P1-183 Influenza vaccination in prostate cancer survivors in the electronic health record era Journal of Epidemiology and Community Health. 65. DOI: 10.1136/Jech.2011.142976D.76 |
0.452 |
|
| 2010 |
Wallner L, Porten S, Meenan R, O'Keefe Rosetti M, Calhoun E, Sarma A, Clemens JQ. 485 PREVALENCE AND SEVERITY OF URINARY INCONTINENCE AND ASSOCIATED QUALITY OF LIFE IN A MANAGED CARE POPULATION OF MEN AND WOMEN Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.560 |
0.321 |
|
| 2010 |
Jackson R, Casanova N, Wallner L, Dunn R, Hedgepeth R, Faerber G, Wei J. 2091 Delayed Hematuria Following Photoselective Vaporization Of The Prostate The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.2152 |
0.378 |
|
| 2010 |
Wallner L, McGree M, Jacobson D, St. Sauver J, Jacobsen S, Sarma A. 1841 THE EFFECT OF TYPE 2 DIABETES AND HYPERTENSION ON LONGITUDINAL CHANGES IN PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.1780 |
0.351 |
|
| 2009 |
Wallner LP, Porten S, Meenan RT, O'Keefe Rosetti MC, Calhoun EA, Sarma AV, Clemens JQ. Prevalence and severity of undiagnosed urinary incontinence in women. The American Journal of Medicine. 122: 1037-42. PMID 19854332 DOI: 10.1016/J.Amjmed.2009.05.016 |
0.31 |
|
| 2009 |
Seyfried LS, Wallner LP, Sarma AV. Psychosocial predictors of lower urinary tract symptom bother in black men: the Flint Men's Health Study. The Journal of Urology. 182: 1072-7. PMID 19616799 DOI: 10.1016/J.Juro.2009.05.033 |
0.316 |
|
| 2009 |
Wallner LP, Clemens JQ, Sarma AV. Prevalence of and risk factors for prostatitis in African American men: the Flint Men's Health Study. The Prostate. 69: 24-32. PMID 18802926 DOI: 10.1002/Pros.20846 |
0.427 |
|
| 2009 |
Wallner LP, McGree M, Jacobson DJ, St. Sauver JL, Jacobsen SJ, Sarma AV. THE EFFECT OF METABOLIC CONDITIONS ON PROSTATE CANCER RISK OVER 15 YEARS OF FOLLOW-UP: THE OLMSTED COUNTY STUDY Journal of Urology. 181: 166-167. DOI: 10.1016/S0022-5347(09)60478-X |
0.436 |
|
| 2008 |
Wallner LP, Sarma AV, Lieber MM, St Sauver JL, Jacobson DJ, McGree ME, Gowan ME, Jacobsen SJ. Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3588-92. PMID 19064575 DOI: 10.1158/1055-9965.Epi-08-0050 |
0.47 |
|
| 2008 |
Sarma AV, Wallner L, Jacobsen SJ, Dunn RL, Wei JT. Health seeking behavior for lower urinary tract symptoms in black men. The Journal of Urology. 180: 227-32. PMID 18499182 DOI: 10.1016/J.Juro.2008.03.032 |
0.356 |
|
| 2006 |
Sarma AV, McLaughlin JC, Wallner LP, Dunn RL, Cooney KA, Schottenfeld D, Montie JE, Wei JT. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. The Journal of Urology. 176: 1108-13. PMID 16890703 DOI: 10.1016/J.Juro.2006.04.075 |
0.451 |
|
| 2006 |
Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. Cancer Research. 66: 3087-95. PMID 16540658 DOI: 10.1158/0008-5472.Can-05-3447 |
0.36 |
|
| 2006 |
Sarma AV, Wallner LP, Daignault S, Wei JT. 126: Metabolic Syndrome and Risk of Prostate Cancer: Nhanes 2001-2002 Journal of Urology. 175: 40-40. DOI: 10.1016/S0022-5347(18)32393-0 |
0.418 |
|
| Show low-probability matches. |